InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Sharon Mates, Chairman, President & CEO, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 30 open-market SEC Form 4 transactions: 0 purchases worth $0 and 30 sales worth $55.4M, reported from Oct 14, 21 to Dec 5, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 50.2K | $84.69 | $4.2M |
| Dec 4, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 27.7K | $86.00 | $2.4M |
| Aug 30, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 28.2K | $73.32 | $2.1M |
| Aug 29, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 29.8K | $73.25 | $2.2M |
| Aug 28, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 32.5K | $73.70 | $2.4M |
| Aug 27, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 23.7K | $73.93 | $1.7M |
| Aug 26, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 22.7K | $74.59 | $1.7M |
| Aug 23, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 28.7K | $74.46 | $2.1M |
| Aug 22, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 35.0K | $75.47 | $2.6M |
| Aug 21, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 44.1K | $77.98 | $3.3M |
| Mar 11, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 14.5K | $67.33 | $942K |
| Mar 7, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 32.0K | $66.93 | $2.1M |
| Feb 26, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 12.5K | $70.11 | $874K |
| Feb 2, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 17.4K | $67.42 | $1.2M |
| Jan 18, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 67.6K | $66.25 | $4.4M |
| Jan 17, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 30.6K | $66.66 | $2.0M |
| Jan 16, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 66.0K | $67.76 | $4.4M |
| Sep 19, 23 | ITCIIntra-Cellular Therapies, Inc. | SELL | 44.4K | $54.17 | $2.4M |
| Sep 18, 23 | ITCIIntra-Cellular Therapies, Inc. | SELL | 28.1K | $53.96 | $1.5M |
| Mar 13, 23 | ITCIIntra-Cellular Therapies, Inc. | SELL | 19.2K | $45.06 | $863K |
| Mar 10, 23 | ITCIIntra-Cellular Therapies, Inc. | SELL | 35.0K | $43.28 | $1.5M |
| Feb 24, 23 | ITCIIntra-Cellular Therapies, Inc. | SELL | 22.6K | $47.03 | $1.1M |
| Feb 21, 23 | ITCIIntra-Cellular Therapies, Inc. | SELL | 22.9K | $49.60 | $1.1M |
| Dec 13, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 33.1K | $55.00 | $1.8M |
| Feb 24, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 11.2K | $52.35 | $589K |
| Feb 22, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 15.2K | $55.73 | $846K |
| Jan 10, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 27.1K | $41.72 | $1.1M |
| Oct 18, 21 | ITCIIntra-Cellular Therapies, Inc. | SELL | 8.2K | $40.00 | $328K |
| Oct 15, 21 | ITCIIntra-Cellular Therapies, Inc. | SELL | 40.4K | $40.00 | $1.6M |
| Oct 14, 21 | ITCIIntra-Cellular Therapies, Inc. | SELL | 1.4K | $40.00 | $57K |